Current Hematologic Malignancy Reports : Impact Factor & More
eISSN: 1558-822XpISSN: 1558-8211
Share this on:
Key Metrics
CiteScore 
6.5
Eigenfactor
0.001 - 0.005
H-Index
40
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.27
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Hematologic Malignancy Reports
Current Hematologic Malignancy Reports Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | CURRENT MEDICINE GROUP |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Hematologic Malignancy Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Hematologic Malignancy Reports
Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.
- 25 Apr 2026
- Current hematologic malignancy reports
Germline DDX41 Variants: Current Understanding and Future Directions.
- 23 Apr 2026
- Current hematologic malignancy reports
Clonal Signatures of Telomere Biology Disorders.
- 14 Apr 2026
- Current hematologic malignancy reports
Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms.
- 7 Mar 2026
- Current hematologic malignancy reports
The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes.
- 6 Mar 2026
- Current hematologic malignancy reports
When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia.
- 26 Feb 2026
- Current hematologic malignancy reports
Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.
- 25 Apr 2026
- Current hematologic malignancy reports
Germline DDX41 Variants: Current Understanding and Future Directions.
- 23 Apr 2026
- Current hematologic malignancy reports
Clonal Signatures of Telomere Biology Disorders.
- 14 Apr 2026
- Current hematologic malignancy reports
Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms.
- 7 Mar 2026
- Current hematologic malignancy reports
The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes.
- 6 Mar 2026
- Current hematologic malignancy reports
When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia.
- 26 Feb 2026
- Current hematologic malignancy reports
FAQs on Current Hematologic Malignancy Reports
How long has Current Hematologic Malignancy Reports been actively publishing? 
What is the publishing frequency of Current Hematologic Malignancy Reports?
How many articles did Current Hematologic Malignancy Reports publish last year?
What is the eISSN & pISSN for Current Hematologic Malignancy Reports?
What is Citescore for Current Hematologic Malignancy Reports?
What is the H Index for Current Hematologic Malignancy Reports ?
What is SNIP score for Current Hematologic Malignancy Reports?
What is the SJR for Current Hematologic Malignancy Reports?
Who is the publisher of Current Hematologic Malignancy Reports?
